Activated factor VII-Antithrombin complex (FVIIa-AT) in patients with acute promyelocytic leukemia (APL)

被引：0
|
作者：
Balducci, D. [1 ]
Russo, L. [1 ]
Vignoti, A. [1 ]
Marchetti, M. [1 ]
Woodhams, B. [2 ]
Morrissey, J. [3 ]
Barbui, T. [1 ]
Falanga, A.
机构：
[1] Osped Riuniti Bergamo, Dept Haematol, Bergamo, Italy
[2] Stago R&D, Gennevilliers, France
[3] Univ Illinois, Dept Biochem, Urbana, IL USA
来源：
THROMBOSIS RESEARCH | 2007年 / 120卷
关键词：
D O I：
10.1016/S0049-3848(07)70179-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S153 / S153
页数：1
相关论文
共 50 条
  • [21] Clinical Characteristics and Outcomes In Patients With Acute Promyelocytic Leukemia (APL) and Hyperleukocytosis
    Daver, Naval
    Kantarjian, Hagop M.
    Faderl, Stefan H.
    Garcia-Manero, Guillermo
    O'Brien, Susan
    Ferrajoli, Alessandra
    Verstovsek, Srdan
    Popat, Uday
    Hosing, Chitra M.
    Kadia, Tapan M.
    Cortes, Jorge E.
    Ravandi, Farhad
    Anderlini, Paolo
    BLOOD, 2013, 122 (21)
  • [22] ACTIVATED FACTOR VII-ANTITHROMBIN COMPLEX PLASMA CONCENTRATION IS A PREDICTOR OF TOTAL AND CARDIOVASCULAR MORTALITY IN PATIENTS WITH CORONARY ARTERY DISEASE AND ITS PROGNOSTIC SIGNIFICANCE IS IMPROVED BY USING FACTOR VII GENOTYPE-SPECIFIC THRESHOLD LEVELS
    Martinelli, N.
    Girelli, D.
    Baroni, M.
    Guarini, P.
    Tosi, F.
    Lunghi, B.
    Woodhams, B.
    Bernardi, F.
    Olivieri, O.
    THROMBOSIS RESEARCH, 2014, 133 : S16 - S16
  • [23] Tissue factor and factor VII gene polymorphisms influencing FVIIA-AT plasma concentration are not uniformly associated with mortality in patients with stable coronary artery disease
    Sartori, F.
    Tosi, F.
    Lunghi, B.
    Guarini, P.
    Baroni, M.
    Branchini, A.
    Woodhams, B.
    Girelli, D.
    Olivieri, O.
    Bernardi, F.
    Martinelli, N.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 708 - 708
  • [24] Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL)
    G Garcia-Manero
    HM Kantarjian
    S Kornblau
    E Estey
    Leukemia, 2002, 16 : 1888 - 1888
  • [25] Effect of Asparaginase and Dexamethasone on FVIIa-at Complex and F1.2 in Children with Acute Lymphoblastic Leukemia: Evidence of Hypercoagulable State
    Athale, Uma H.
    Atkinson, Helen H. M.
    Athale, Abha
    Nayiager, Trishana
    Chan, Anthony
    BLOOD, 2015, 126 (23)
  • [26] Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL)
    Garcia-Manero, G
    Kantarjian, HM
    Kornblau, S
    Estey, E
    LEUKEMIA, 2002, 16 (09) : 1888 - 1888
  • [27] Molecular relapse monitoring and treatment in acute promyelocytic leukemia (APL) patients.
    Shuravina, E. N.
    Parovitchnikova, E. N.
    Misyurin, A. V.
    Demidova, I. A.
    Isaev, V. G.
    Savchenko, V. G.
    BLOOD, 2006, 108 (11) : 183B - 183B
  • [28] High incidence of thromboembolic events in leukemic patients with acute promyelocytic leukemia (APL).
    Schwarz, J
    Lemez, P
    Lukasova, M
    Vorlova, Z
    Haskovec, C
    Michalova, K
    Vitek, A
    Suchmova, M
    Jirasek, A
    BLOOD, 1996, 88 (10) : 3404 - 3404
  • [29] The results of molecular relapses treatment in acute promyelocytic leukemia (APL) patients.
    Shuravina, EN
    Parovitchnikova, EN
    Demidova, IA
    Olshanskaia, YV
    Misiurin, AV
    Savchenko, VG
    BLOOD, 2005, 106 (11) : 203B - 203B
  • [30] ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN VERY ELDERLY PATIENTS (> 70 YEARS)
    Latagliata, R.
    Finsinger, P.
    Breccia, M.
    Minotti, C.
    Carmosino, I.
    Cannella, L.
    Volpicelli, P.
    Vozella, F.
    Stefanizzi, C.
    Loglisci, G.
    Cimino, G.
    Foa, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 508 - 508
12345